**Close price adjusted for splits and dividend and/or capital gain distributions. I think IXC has the potential to do better. View listing photos, review sales history, and use our detailed real estate filters to find the perfect place. Advertise on HotCopper. Toubani Resources is an exploration and development company with a focus on developing a gold platform in West Africa. . . But there are two key factors that make me hope that the BoD pursues the Phase 2, but I worry that JP and co will push for the. here (arrow) per the NEU chart Close now to breaking trend and establishing a more upper trend into results IMO IXC Price at posting: 40. Invex Files Pre-IND/Type B Meeting Request with US FDA IXC is a long term play mate, not a daytraders plaything as too illiquid. ASX - Day TradingAs thread states post your questions here and let’s start compiling a list. ASX - By Stock. ASX - By Stock. Market . IXC Price at posting. , page-4. 0 Great. ASX - General. Latest Posts. Plus, the opportunity to explore other conditions, including hydrocephalus and meningitis. Created with Sketch. Will management look for an early exit or are they wanting to take to market? Just came across IXC from another stock @JabraD posts on. All the latest Invex Therapeutics Ltd (ASX:IXC) share price movements, news, expert commentary and investing advice from The Motley Fool Australia. The Calmer Co (ASX:CCO) breaks new ground in Australian Retail with Kava shots to launch in Coles from January 2024Hi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. ASX - By Stock. ASX - Short Term Trading. Created with Sketch. , page-196. 10 Upvote. 4. That is fair and as I mentioned in my initial post when buying, the business is worth the cash in ST. ASX - By Stock. . Lucky for you all IXC still sits at only 60 cents. Click for more information. Charts. 38 was the valuation MST gave IXC 9 months ago Considering we are now even further de-risked, getting to the end result, wonder what MST valuation would be now. . 59 before first real pull back (those lines will be used in the future, they always set it up for that reason, being $3. ASX - By Stock. ASX - Day Trading It is certainly an interesting case study regarding management strategy; that noted strategy would work during fair or bullish markets as participants are acting rationally (and by sticking to their knitting during Covid Crash the IXC share price bounced back heavily with Phase II results - so perhaps thats what they were thinking would happen. ASX - By Stock. Australia's largest stock trading and investment forum Australia's #1 stock forumCreated with Sketch. Latest Posts ForumsThis doesn't mean that IXC is doomed, just that things are more a gamble than an investment at the moment. Is it just me or has IXC gone very quiet. ASX - By Stock. Created with Sketch. Created with Sketch. 30 order I had out there for 2-3 weeks. Latest Posts. Forex. IXC Valuation Report MST. . Latest Posts. ASX - Short Term Trading. It seems a massive hole within the industry of treatment *cough cough* IXC Also surprised by the amount of activity and people who have the disease. Forums. . 0. Top 20 remains holding 58% compared to 58. Created with Sketch. IXC Valuation Report MST. , page-3. 00% 21. Anyone had a look at this or put an application in for some stock in the IPO?, page-2. I guess that's why retail performs so poorly on average, so many think they are long term investors but can't hold onto their shares for more. 54am 24/11/2023 ? HotCopper has news, discussion, prices and market data on INCA MINERALS LIMITED. Market Cap $102. . This is fantastic news and I appreciate the fact that it has not been heavily hyped by the company, makes you wonder what else is being worked on. Strong buy side, sell side still very thin. , page-3. Australian finance news, stock quotes, currency information and blogs0. . Ceasing to be a substantial holderAustralian finance news, stock quotes, currency information and blogsQuarterly Activities/Appendix 4C Cash Flow ReportInvex Granted European Patent for Exenatide in Hydrocephalus. , page-4. Australia's largest stock trading and investment forum Australia's #1 stock forumInvestor PresentationMRDMount Ridley Mines REE Project: Drilling confirms continuous high-grade mineralisation. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. 0¢ Sentiment: Buy Disclosure: HeldHotCopper has news, discussion, prices and market data on GENESIS MINERALS LIMITED. ASX - General. . Created with Sketch. Given the quality of the posters on the IXC thread I am confident others will do the same. ASX - Day Trading. 7% #asx #ausbiz 23 Jun 2023 06:06:11Not been following IXC but it seems that this Orphan Drug Designation for TBI now have $0 value due to the other Phase III trial update and the company is. If IXC is positioning itself as a takeover target and the trial endpoints allow for it, it would make sense to provide early readouts. Hopefully that placement overhang will be removed today tomorrow and the share price will catch up. IXC Price at posting: 44. Umbrella Society is a proud Living Wage Employer! Greater Victoria's official living wage has been adjusted to $25. 3¢. , page-4. ASX - General. 79 -0. 8 Upvote Created with Sketch. ASX - Short Term Trading. . 0. Interexchange Carrier, also known as IXC, is a telco that mainly provides long-distance communication services. Below is the broker data for IXC November to. IXC Valuation Report MST. Latest Posts ForumsHalf Yearly Report and AccountsWith debt too expensive and lots of very discounted capital raisings especially in the microcap part of the market, I'd like to think that IXC can take advantage of the fact that they have cash. To work out how much Presendin is worth, we can look at the costs of IIH to the American health care system. Forums. Market . Forums. Can't see how this doesn't push up soon, page-508. Latest Posts. Good fundamental research starting points for IXC:Summary: IXC FactsheetMST Analyst Equity Research ReportFiftyOne Capital ReportPresentation - Tom Duthy. 79 -0. Australia's largest stock trading and investment forum Australia's #1 stock forum Australia's #1 stock forumUK R&D Tax Rebate. Created with Sketch. . Advertise on HotCopper. Update - Notification regarding unquoted securities - IXC. ASX - By Stock. P3 will be kicked off in early CY2021. 76 (-1. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentNotice of Annual General Meeting/Proxy Form. $45M MC $30M Cash and a $1. , page-3. Australia's largest stock trading and investment forum Australia's #1 stock forumIXC peaked at $1. Cannot wait. Trading HaltIXC Valuation Report MST. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. ASX - Day Trading. Global Phase 3 Trial of Presendin to Launch in Q4 2021Invex receives IND approvalInvex Receives Written Response from FDA on Type C Meeting, page-2. Market . The IXC stock may trade low due to this wider macroeconomic issues, but the business itself is top 5% to its peers merely from the fact of having no future funding requirements and that if the trial is a success having close to immediate revenues and default alive status via Peptron manufacturing contract fulfilling demand on potential FDA. . ASX - Day Trading. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Company has options because they have cash. HotCopper has news, discussion, prices and market data on IONIC RARE EARTHS LIMITED. IXC on the other hand with nearer catalysts has already done its basing cycle Of course different stock different TAMS etc etc, probably why IMU is worth 640 mill MC and IXC 28 mill MC But again its why IXC is offering so much more in terms of value atm plus risk v reward All IMO of course, but yeh maybe some IMU investors pop across. ASX - Day Trading. ASX - Day Trading0. 0 Great analysis. ASX - Day TradingQuarterly Activities/Appendix 4C Cash Flow ReportMarch 20 (Reuters) - Invex Therapeutics Ltd (IXC) : APPROVAL TO COMMENCE IIH EVOLVE PHASE III CLINICAL TRIAL RECEIVED FROM BUNDESINSTITUT FÜR. Invex Receives Approval for Paediatric Plan from the EMA, page-2. As thread states post your questions here and let’s start compiling a list. Advertise on HotCopper. 1950. , page-4. ASX - Day TradingNotice of Webinar & Investor PresentationCreated with Sketch. Charts. Both approaches can work, but it is not wise to confuse the two. Created with Sketch. (IXC) - see HotCopper and other bloggers' predictions - TipRanks. ASX - By Stock. ASX - By Stock. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentCreated with Sketch. Appendix 4E and Annual Report, page-3. Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. , page-2. Expand. Created with Sketch. Forums. Last updated 10. LATEST NEWS: Toubani Resources releases MRE update for Kobada gold project, Mali. ASX - By Stock. The fact it recovered and closed about the 1. Hi All, I have decided to make an IXC broker data thread, as my PAR broker data thread was very well received. ASX - Day Trading. Invex Granted Type C Meeting with FDAAppendix 4E and Annual Report to shareholders. 26 area could be wrong and it could go for example to $3. Release Date: 21/11/22 08:18; Summary: First Patient Randomised in IIH EVOLVE Phase III Trial; Price Sensitive: Yes; Download Document 205. $100-200k might be the minimum for the market to take notice. AX stock on Yahoo Finance. Discover historical prices for IXC. ASX - By Stock. . 333334. Charts. It was well aware of the claims made, released such information in the prospectus (and still had a hugely successful IPO), and would have done their due diligence before entering into any agreements with the University. ASX - Day TradingWith debt too expensive and lots of very discounted capital raisings especially in the microcap part of the market, I'd like to think that IXC can take advantage of the fact that they have cash. . Last edited by jellyroll: 27/02/23. , page-2. View daily, weekly or monthly formats back to when Invex Therapeutics Ltd stock was issued. Created with Sketch. ASX - Short Term Trading. Charts. , page-5. . ASX - Day TradingIf IXC is positioning itself as a takeover target and the trial endpoints allow for it, it would make sense to provide early readouts. I think having this out we can discuss on the way. Forums. Forums. . 6million shares?, and if so is anyone worried about this, release date 29th. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-4. Invex to Present at Upcoming Tech Biotech Broker BriefingCreated with Sketch. ASX - By Stock. ASX - Day TradingCreated with Sketch. 05. Thought that this would be worthy of its own thread, a great starting place for those new to IXC and arguably the best presentation to date, Worth a. Consequently, this would result in faster market penetration and an accelerated timeline to peak sales. Latest Posts. 333334. Created with Sketch. , page-5. . Created with Sketch. AX stock on Yahoo Finance. You’d be surprised the volume that comes in when this happenes, but by that stage you’ll be 100% up whilst the opportunity cost traders will be trying to catch the move up. sentiment based on opinions from HotCopper and others. 31% more bullish than other Healthcare sector stocks. Market . Plans & Pricing. ASX - General. Forums. Good fundamental research starting points for IXC:Summary: IXC FactsheetMST Analyst Equity Research ReportFiftyOne Capital ReportPresentation - Tom Duthy. Created with Sketch. Created with. no point selling now. IXC Valuation Report MST. ASX - By Stock. ASX - Day TradingCreated with Sketch. ASX - General. Trading HaltCreated with Sketch. US data averaged $2314 per person in direct medical care, the total average direct cost per IIH admission was 4x that or $9256. IXC needs to be proactive and release a statement. Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only. Created with Sketch. Very impressive. ASX - By Stock. . Created with Sketch. I think having this out we can discuss on the way. I think having this out we can discuss on the way. Spot on - filled the 1. . . 6% $DLM 50. Not sure what software this is but is there a way you can send the document itself, is a tad tough to read it with the photo you sent, if not all good, page-4. A new thread to put trading comments / reasoning / opinions in. ASX - By Stock. 6 Upvote. 375,000. Market open. 1. " Seems a bit rough, anyone would think they are trying to minimise the number of SH who 'attend' the AGM. Proposed Capital Return to Shareholders of $14. Share. **Close price adjusted for splits and dividend and/or capital gain distributions. . Market . 4KB OECCreated with Sketch. I bought the chart from base lows looking for a trade. IXC Valuation Report MST. . . IXC has not had a decent bounce at all as yet, maybe still some sellers lurking. a shell trading below cash backing, ripe. . Interexchange Carrier, also known as IXC, is a telco that mainly provides long-distance communication services. Anyone buying now can carry to $5 and then sell a few prior to readout as insurance against losing everything in the coin flip. Created with Sketch. Investor PresentationInvex Successfully Concludes Protocol Assistance with EMACreated with Sketch. . Created with Sketch. Invex Therapeutics Ltd. Below is the broker data for IXC November to. 0¢ Sentiment: Buy Disclosure: Held Bumping up this thread as $3. Market . The Phase III raise encompassed the costs for a go-it-alone reformulation strategy, with Bell Potter suggesting in a Q&A with IXC that they saved $5-6M in going with Peptron for their reformulation supply/manufacturing, alongside 12 months in time. , page-35. Market . IXC current EV is close to $0 so again Im not sure what OSL valuation is but I dont think it stacks up as good as IXC and where IXC is at in its timeline. All the latest Invex Therapeutics Ltd (ASX:IXC) share price movements, news, expert commentary and investing advice from The Motley Fool. A promising development for IXC, a company with a current Phase III trial that is expected to finish dosing in 12 months time, We hear from a patient from the Phase II trial completed 2 years ago, with our current Phase III trial ongoing as we speak: Tony Grist - 5th largest holder in IXC Tom Henderson - 2nd largest holder in IXC Kim Hogan - 6th largest holder in IXC and now Simon Joyner - 14th largest holder in IXC Just a background of this board of advice. 9 more clinical sites to be rapidly activated in a country with a growing incidence of IIH cases. , page-20. For IXC I see the risk in one indication, comparatively lower TAM than others and different formulation for a week duration while phase II used daily. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Share "Online registration will open 30 minutes before the Meeting. IAMIncome Asset Management to boost bond sales through partnership with Netwealth. 1. 1073084. Appendix 4C - quarterlyAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. 38 was the valuation MST gave IXC 9 months ago Considering we are now even further de-risked, getting to the end result, wonder what MST valuation would be now. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. Created with Sketch. IXC Price at posting: $1. See page-34. I find this very intriguing and positive that in last few weeks about 1. Last edited by ejjwj: 28/06/23. IXC has alot of catching up to do. wonder if the GLP-1 agonist referred to in this media release. ASX - By Stock. Hopefully they hit the miracle, at least I get something back from this if it goes balls up which in the bio world at the moment is highly likely. 5¢ INVEX THERAPEUTICS LTD - Discussion. 0. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure. 7KB AVG: 22/11/2023 1:08 PM : 2023 AVG AGM Addresses and Presentation 35 pages 3. HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. Withdrawal of AGM Resolutions, page-2. . , page-6. Created with Sketch. Last updated 10. Created with Sketch. Share Ok news not the greatest but I dont think its as bad as people gonna re-act (mainly retailers) Primary endpoint remains unchanged Protocol changes focus on reordering secondary endpoints - replacing PMD with the more. , page-5. About 90 percent of the U. The company can always acquire something new or do some capital returns. Forums. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. . pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. 30 is a good sign as well. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-7. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Invex Therapeutics Limited (ASX:IXC) is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure, such as Idiopathic Intracranial Hypertension (IIH), acute stroke and traumatic brain injury. When can we expect some update or. 0. Re-purposed FDA drug for other illness with amazing effect as domenstrated in P2 results which ever drove sp to $2. More progress made towards the start of Phase III, we have now made it on to the clinicltrials. ASX - By Stock. Market Wrap - Top 3 Gainers #ASXGainers: $IXC 54. We are a team of expert financial advisers each specialising in different, yet complementary areas. ASX - Day TradingMEDSAFE and Ethics Approval for IIH EVOLVE Trial in NZCreated with Sketch. IXC Price at posting: 44. ASX - Day TradingAnother day…another approval. , page-188. 3¢. ASX - Day TradingCreated with Sketch. Report Created with Sketch. . Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving. Notice of Annual General Meeting/Proxy FormInvex Receives Written Response from FDA on Type C MeetingNotification of cessation of securities - IXC. . ASX - By Stock. 50%. Market Cap $16. . Forums. Last updated 15. Very tempted to buy them back today at 19c. is 19. Created with Sketch. Australia's largest stock trading and investment forum Australia's #1 stock forumInvex Successfully Concludes Protocol Assistance with EMA, page-2. Forums. Target our investor community with our suite of Hotcopper Advertising opportunities. I'm thinking of flying there myself!Prof Alex Sinclair is to present in Melbourne and Sydney next. The Phase III raise encompassed the costs for a go-it-alone reformulation strategy, with Bell Potter suggesting in a Q&A with IXC that they saved $5-6M in going with Peptron for their reformulation supply/manufacturing, alongside 12 months in time. IXC Price at posting: 37. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-5. DJPIN. Appendix 4C - quarterly There are thousands of people out there with IXC shares, you simply can not predict when one is going to sell and how much they are going to sell. Created with Sketch. But posts 3-4 times a day that are the same charts we can all see, about a -3% move on $10k volume, paired with hysteria and paranoia, its just not.